跳至主要内容
临床试验/PER-039-02
PER-039-02已完成未知

Randomized, Double Blind, Multicenter Study of the Safety and Efficacy of Valdecoxib 40 mg Once Daily vs. Diclofenac 75 mg Twice Daily in Subjects With Acute Low Back Pain

PFIZER S.A.,0 个研究点目标入组 0 人开始时间: 2002年5月22日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
PFIZER S.A.,

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Acute low back pain, defined as either class 1a or class 2a according to the Quebec Task Force Classification and categorized as moderate-severe in the Pain Intensity Categorical Scale and Visual analogue score (VAS) greater or equal to 50 mm
  • Acute low back pain was to have started at least 72 hours prior to inclusion in the trial and more than 6 weeks after the last episode of acute low back pain
  • History of at least 1 reported episode of acute low back pain in the last 5 years

排除标准

  • History of inflammatory arthritis, chronic pain, metastasis, Paget´s disease, or other diseases known to cause pain
  • Moderate to severe scoliosis
  • Back pain due to major trauma or visceral disorder
  • Unwilling to refrain from commencing concomitant physiotherapy
  • Active or suspected esophageal, gastric pyloric channel, or duodenal ulceration or bleeding within 30 days prior to the first dose of study medication
  • Any known laboratory abnormality, which in the opinion of the investigator, would contraindicate study participation
  • Subject was pregnant or lactating woman , or was a woman of childbearing potential not using an acceptable method of contraception

研究者

发起方
PFIZER S.A.,

相似试验

未知
3 期
A Randomized, Double-blinded, Multicenter Study of Denosumab Compared With Zoledronic acid (Zometa) in the Treatment of Bone Metastases in Subjects with Advanced Breast CancerAdvanced breast cancer with bone metastases
JPRN-jRCT2080220875DAIICHISANKYO Co.,Ltd.1,960
进行中(未招募)
不适用
A Randomized, Double-blind, Multi-Center Study to Evaluate Safety and Immunogenicity of One Dose of Four FLUVAL AB-like (Trivalent, Whole Virus, Aluminium Phosphate Gel Adjuvanted) Influenza Vaccines Containing 3.5µgHA, 6µgHA, 9µgHA or 15 µgHA of Seasonal A/H1N1, A/H3N2 and B Influenza Antigens in Non-elderly Adult and Elderly SubjectsImmunization of healthy people against influenza virus infectionMedDRA version: 14.0Level: LLTClassification code 10059430Term: Influenza immunizationSystem Organ Class: 10042613 - Surgical and medical procedures
EUCTR2011-003166-32-HUOmninvest Ltd.
进行中(未招募)
不适用
A study of an experimental antibiotic (solithromycin) compared to another antibiotic (moxifloxacin) both taken by mouth in adults with pneumonia.Community-Acquired Bacterial PneumoniaMedDRA version: 14.1Level: LLTClassification code 10010120Term: Community acquired pneumoniaSystem Organ Class: 100000004862
EUCTR2012-003971-20-LVCempra Pharmaceuticals, Inc.860
进行中(未招募)
1 期
A study assessing the efficacy and safety of solithromycin compared to moxifloxacin in the treatment of adults with community-acquired bacterial pneumonia.
EUCTR2013-003453-13-ROCempra Pharmaceuticals, Inc.863
进行中(未招募)
不适用
A study of an experimental antibiotic (solithromycin) compared to another antibiotic (moxifloxacin) both taken by mouth in adults with pneumonia.Community-Acquired Bacterial PneumoniaMedDRA version: 16.1Level: LLTClassification code 10010120Term: Community acquired pneumoniaSystem Organ Class: 100000004862
EUCTR2012-003971-20-EECempra Pharmaceuticals, Inc.860